Search

Your search keyword '"EBC‐46"' showing total 24 results

Search Constraints

Start Over You searched for: Descriptor "EBC‐46" Remove constraint Descriptor: "EBC‐46"
24 results on '"EBC‐46"'

Search Results

1. Response to tigilanol tiglate in dogs with mast cell tumors.

2. Response to tigilanol tiglate in dogs with mast cell tumors

3. Floral attraction and flower visitors of a subcanopy, tropical rainforest tree, Fontainea picrosperma

4. The P450 multigene family of Fontainea and insights into diterpenoid synthesis

5. Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate

6. Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate

7. Floral attraction and flower visitors of a subcanopy, tropical rainforest tree, Fontainea picrosperma.

8. The P450 multigene family of Fontainea and insights into diterpenoid synthesis.

9. Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate.

10. Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate.

11. Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors

12. Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate.

13. Floral attraction and flower visitors of a subcanopy, tropical rainforest tree, Fontainea picrosperma

14. Wound formation, wound size, and progression of wound healing after intratumoral treatment of mast cell tumors in dogs with tigilanol tiglate

15. Floral and reproductive biology of the medicinally significant rainforest tree, Fontainea picrosperma (Euphorbiaceae).

16. Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate

17. Population genetic analysis of a medicinally significant Australian rainforest tree, Fontainea picrosperma C.T. White (Euphorbiaceae): biogeographic patterns and implications for species domestication and plantation establishment.

18. Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46)

19. Reproductive biology, flowering and genetics of Fontainea picrosperma (Euphorbiaceae)

20. Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors

21. Population genetic analysis of a medicinally significant Australian rainforest tree, Fontainea picrosperma C.T. White (Euphorbiaceae): biogeographic patterns and implications for species domestication and plantation establishment

22. Phase 1 dose-escalation study of EBC-46 given by intratumoral injection to patients with refractory cutaneous and subcutaneous tumors

23. Phase I dose-escalation study to determine the safety, tolerability, preliminary efficacy and pharmacokinetics of an intratumoral injection of tigilanol tiglate (EBC-46).

24. Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors.

Catalog

Books, media, physical & digital resources